Press release
Introducing Edoxaban Impurity 103 - Advanced Reference Standard for Analytical Precision
Pune, India - July 2025 - Aquigen Biosciences is proud to announce the addition of Edoxaban Impurity 103 to its premium portfolio of analytical standards for pharmaceutical R&D. With rising demands in the development and regulatory scrutiny of anticoagulant APIs, having access to highly characterized impurity standards is critical for pharmaceutical innovators worldwide.What is Edoxaban Impurity 103?
For full specifications, see Aquigen's product page for Edoxaban Impurity 103:
https://aquigenbio.com/product/edoxaban-impurity-103/
Edoxaban Impurity 103, also known by its CAS number 480450‐85‐9, is a structurally defined process-related impurity of Edoxaban-an FDA‐approved factor Xa inhibitor used in stroke prevention and thrombosis treatments.
This impurity exists as a stable ethyl ester intermediate, with a chemical formula C21H31N5O5S and a molecular weight of 465.6 g/mol.
Characterized meticulously-including NMR, LC-MS, and purity analysis-it is supplied in its free base form and also as a TFA salt, ensuring researchers can select the most chemically appropriate form for their methods.
Why Edoxaban Impurity 103 Matters
Regulatory compliance: A necessary reference for AMV (analytical method validation), QC checkpoints, and ANDA filings.
Process optimization: Enables formulation scientists to track impurity formation and ensure robust synthesis of Edoxaban APIs.
Traceability excellence: Can be matched against USP/EP pharmacopeial standards for increased traceability and regulatory assurance.
Versatile application: Foundational for impurity profiling, stability studies, forced degradation testing, and establishing impurity specifications.
Technical Specifications
Chemical Name:
Ethyl 2‐(((1S,2R,4S)‐4‐(dimethylcarbamoyl)-...‐oxoacetate), trifluoroacetate salt (TFA).
Formats:
Free base or TFA salt.
Shipping & Storage:
Ambient temperature shipping; store at controlled room temperature.
Origin:
Manufactured in India with full batch certificates of analysis.
Technical sheets and SDS documents are available upon request.
Explore Related Impurities
Edoxaban Impurity 100 - Chloro‐pyridinyl Oxo-Acetic Acid
Overview: Small chemical weight impurity (C7H5ClN2O3, 200.6 g/mol, CAS 552850‐73‐4) found during API intermediate degradation.
Applications: Ideal for analyzing early-stage process variation and degradation products.
Details: Aquigen's product page: https://aquigenbio.com/product/edoxaban-impurity-100/
Edoxaban Impurity 101 - Intermediate Cyclohexyl-Pyridinyl Derivative
Overview: C12H20N4O4 impurity (molecular weight 284.3 g/mol) associated with mid-stage synthesis tlcstandards.comsynzeal.com.
Applications: Supports method validation targeting mid-pathway process impurities.
Details: Aquigen's product page: https://aquigenbio.com/product/edoxaban-impurity-101/
Including these related impurities in your analytical toolkit provides a powerful, integrated platform to secure purity, traceability, and regulatory compliance throughout Edoxaban development.
Broad Impurity Standards Portfolio
Discover the full range of Edoxaban impurity reference standards at Aquigen's dedicated category page:
https://aquigenbio.com/products/impurity-standards/edoxaban/
This category includes a carefully curated spectrum of impurities-from early synthetic fragments to late-stage metabolites and nitrosamine analogs-supporting any stage of Edoxaban research and quality assessment.
Aquigen's Edge in Analytical Standards
Comprehensive data support: Certificates of Analysis (COA), NMR, LC-MS, and UV data available for every impurity.
Regulatory-grade production: Manufactured under GLP-aligned conditions in certified labs.
Flexible packaging: Multiple pack sizes to scale with your project needs.
Global logistics: Exported worldwide with ambient-temperature shipping-no cold chain needed.
Who Benefits?
Pharma R&D teams engaged in API synthesis and impurity profiling.
Contract Research Organizations (CROs) validating analytical methods.
Generics manufacturers preparing ANDA submissions.
Regulatory consultants overseeing dossier development and impurity thresholds.
By integrating Edoxaban Impurity 103 and its companion standards in your workflows, you can ensure precise detection of known and unknown impurities, supporting method robustness and regulatory readiness.
Contact:
Aquigen Bio Sciences
281/1, Plot No 41,
Hinjawadi - Pirangut Rd,
Kasar Amboli, Pirangut,
Pune, Maharashtra 412108
Phone: +91 7030123794
Email: bd@aquigenbio.com
Visit: www.aquigenbio.com
About Aquigen Biosciences
Aquigen Biosciences is a leading provider of high-quality reference standards, impurities, and custom synthesis solutions for pharmaceutical research and development. Based in India, Aquigen serves global clients with a strong focus on regulatory compliance, scientific accuracy, and customer-centric support. Our portfolio spans a wide range of API impurities, metabolites, and stable isotope-labeled compounds, all manufactured under stringent quality controls and delivered with comprehensive analytical documentation. At Aquigen, we are committed to advancing pharmaceutical innovation by ensuring researchers and formulators have access to precise, reliable, and traceable chemical standards.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Introducing Edoxaban Impurity 103 - Advanced Reference Standard for Analytical Precision here
News-ID: 4118849 • Views: …
More Releases from Aquigen Bio Sciences

Advancing Pharmaceutical Quality and Regulatory Compliance with Gatifloxacin Imp …
In the ever-evolving landscape of pharmaceutical research, the accuracy of analytical results is paramount-especially when it comes to antibiotic safety. That's why Aquigen Bio has developed high-quality impurity standards for Gatifloxacin, empowering chemists and quality‐control experts to meet the highest regulatory demands worldwide.
One standout in their catalog is Gatifloxacin Impurity 2.
https://aquigenbio.com/product/gatifloxacin-impurity-2/
Though not used therapeutically, this reference standard plays a critical role in:
Quantifying and qualifying impurities in Gatifloxacin formulations
Supporting stability…

Unveiling Tegoprazan Impurity 2: A Critical Reference Standard in P-CAB Drug Dev …
As the pharmaceutical industry advances toward next-generation acid suppression therapies, potassium-competitive acid blockers (P-CABs) like Tegoprazan are emerging as game changers in the treatment of gastroesophageal reflux disease (GERD) and other acid-related conditions. However, to ensure the safety, efficacy, and regulatory compliance of P-CAB-based drugs, identifying and monitoring impurities during synthesis and storage is non-negotiable.
Explore Tegoprazan Category
https://aquigenbio.com/products/impurity-standards/tegoprazan/
One such critical impurity is Tegoprazan Impurity 2 - a process-related compound now available…

Aquigen Biotech Launches High‐Purity Cefoxitin EP Impurity I to Strengthen Pha …
Pune, India - July 16, 2025 - Aquigen Biotech, a global leader in high‐quality pharmaceutical reference standards, today announced the introduction of Cefoxitin EP Impurity I, a critical impurity standard defined in the European Pharmacopoeia (EP) for cefoxitin. This launch enhances Aquigen's full suite of cephalosporin impurity products and reinforces the company's commitment to aiding analytical labs, regulatory teams, and pharmaceutical manufacturers in meeting rigorous quality and safety standards.
https://aquigenbio.com/product/cefoxitin-ep-impurity-i/
1. Introduction…

Unleashing the power of Glutathione-nature's master antioxidant-supporting cellu …
Glutathione is often described as the "master antioxidant" - a small tripeptide composed of glutamine, cysteine, and glycine. It's essential for maintaining cellular health, neutralizing oxidative stress, detoxifying harmful compounds, and supporting immune function. At Aquigen Bio, our high‐quality Glutathione and its precision EP impurities help researchers and industries achieve new heights in formulation, quality control, and analytical confidence.
Explore Glutathione Impurities :
https://aquigenbio.com/products/impurity-standards/glutathione/
Why Glutathione Matters
Cellular Defense: Glutathione protects cells from reactive…
More Releases for Edoxaban
Factor Xa Inhibitor Drugs Market Size in 7MM is expected to grow at a decent CAG …
DelveInsight's "Factor Xa Inhibitor Market Insights, Epidemiology, and Market Forecast- 2034" report delivers an in-depth understanding of the Factor Xa Inhibitor, historical and forecasted epidemiology as well as the Factor Xa Inhibitor market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Discover which therapies are expected to grab the Factor Xa Inhibitor Market Share @ Factor Xa Inhibitor Market Outlook- https://www.delveinsight.com/sample-request/factor-xa-inhibitor-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from…
Deep Vein Thrombosis Market Statistics Expected to Experience Major Growth by 20 …
Key Deep Vein Thrombosis Companies in the market include - Bayer, LEO Pharma, Agen Biomedical, Bristol-Myers Squibb, Sanofi, Ottawa Hospital Research Institute, Daiichi Sankyo, MinaPharm Pharmaceuticals, GlaxoSmithKline, Pfizer, Anthos Therapeutics, Inc., and others.
DelveInsight's "Deep Vein Thrombosis Market Insights, Epidemiology, and Market Forecast-2032 report offers an in-depth understanding of the Deep Vein Thrombosis, historical and forecasted epidemiology as well as the Deep Vein Thrombosis market trends in the United States, EU4…
Periodontal Inflammation Market is Expected to Show a Healthy Growth Rate During …
DelveInsight's "Periodontal Inflammation Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Periodontal Inflammation, historical and forecasted epidemiology as well as the Periodontal Inflammation market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.
Download Sample Report to know more @https://www.delveinsight.com/sample-request/periodontal-inflammation-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr
Periodontal Inflammation Overview
Periodontal diseases are mainly the result of infections and inflammation of the gums and bone that surround and…
Coronary Occlusion Market is Expected to Show a Healthy Growth Rate During the S …
(Las Vegas, Nevada, United States) DelveInsight's "Coronary Occlusion Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Coronary Occlusion, historical and forecasted epidemiology as well as the Coronary Occlusion market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.
Download Sample Report to know more @https://www.delveinsight.com/sample-request/coronary-occlusion-includes-cad-also-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr
Coronary Occlusion Overview
A coronary occlusion is the partial or complete obstruction of blood flow in…
Edoxaban Tosilate Orally Disintegrating Tablets Market Size,Volume,Revenue Trend …
Global Info Research announces the release of the report "Global Edoxaban Tosilate Orally Disintegrating Tablets Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029" . The report is a detailed and comprehensive analysis presented by region and country, type and application. As the market is constantly changing, the report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across…
Edoxaban Tosylate API Market : Future Projections and Industry Insights of the 2 …
Los Angeles, United States,- The research study presented here is a brilliant compilation of different types of analysis of critical aspects of the global Edoxaban Tosylate API market. It sheds light on how the global Edoxaban Tosylate API market is expected to grow during the course of the forecast period. With SWOT analysis and Porter's Five Forces analysis, it gives a deep explanation of the strengths and weaknesses of the global…